Search Results Search Sort by RelevanceMost Recent Medicine and Society Oct 2010 The Personal, Social, and Economic Determinants of Cardiovascular Disease Jane S. Jue, MD, MSc Personal, social, economic, and environmental factors all contribute to the increased incidence of cardiovascular disease in the United States. Virtual Mentor. 2010;12(10):812-817. doi: 10.1001/virtualmentor.2010.12.10.msoc1-1010. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3
Medicine and Society Oct 2010 The Personal, Social, and Economic Determinants of Cardiovascular Disease Jane S. Jue, MD, MSc Personal, social, economic, and environmental factors all contribute to the increased incidence of cardiovascular disease in the United States. Virtual Mentor. 2010;12(10):812-817. doi: 10.1001/virtualmentor.2010.12.10.msoc1-1010.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.